What are West Pharmaceutical Services's total assets?

West Pharmaceutical Services (WST) holds $4.1B in total assets, up 13.6% year over year.

How much debt does West Pharmaceutical Services have?

West Pharmaceutical Services carries $321.0M in total debt against $3.0B of shareholders' equity, a debt-to-equity ratio of 0.11.

How much cash does West Pharmaceutical Services have?

West Pharmaceutical Services holds $521.4M in cash and equivalents.

Can West Pharmaceutical Services cover its short-term obligations?

Its current ratio is 2.71 — current assets exceed current liabilities.

Where does West Pharmaceutical Services's balance sheet data come from?

Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

West Pharmaceutical Services WST Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$791.3M+63.3%	$484.6M-43.2%	$853.9M-4.5%	$894.3M+17.3%
Accounts receivable, net	$574.4M+4.0%	$552.5M+7.9%	$512M+0.9%	$507.4M+3.8%
Inventories	$443.9M+17.7%	$377M-13.3%	$434.7M+4.8%	$414.8M+9.6%
Raw materials	$163.2M-2.2%	$166.9M-3.1%	$172.3M+0.9%	$170.7M+11.0%
Work in process	$103.2M+58.3%	$65.2M-25.3%	$87.3M+10.5%	$79M+24.4%
Finished goods	$177.5M+22.5%	$144.9M-17.2%	$175.1M+6.1%	$165.1M+2.5%
Prepaid expenses and other current assets	$168.6M+36.0%	$124M-8.7%	$135.8M+31.8%	$103M-8.0%
Total current assets	$1.98B+28.6%	$1.54B-20.6%	$1.94B+0.9%	$1.92B+10.2%
Property and equipment, net	$1.73B+9.2%	$1.58B+11.9%	$1.41B+22.0%	$1.16B+9.5%
Accumulated depreciation	$1.5B+6.6%	$1.4B+6.0%	$1.32B+7.8%	$1.23B+6.1%
Operating lease right-of-use assets	4.7%-10,449,999,995%	10,450,000,000%+530,000,000%	9,920,000,000%-520,000,000%	10,440,000,000%+3,510,000,000%
Goodwill	$109.9M+3.7%	$106M-2.3%	$108.5M+1.1%	$107.3M-2.4%
Intangible assets, net	$7.7M-28.7%	$10.8M-28.5%	$15.1M-17.9%	$18.4M-20.0%
Deferred tax assets	$23M+12.2%	$20.5M+61.4%	$12.7M-11.2%	$14.3M+192%
Other non-current assets	$80.1M+7.8%	$74.3M+249%	$21.3M-44.5%	$38.4M+130%
Equity method investments	$212.3M+5.0%	$202.1M-3.8%	$210M+2.5%	$204.9M-1.3%
Total assets	$4.27B+17.2%	$3.64B-4.9%	$3.83B+5.9%	$3.62B+9.1%
Accounts payable	$253.7M+6.0%	$239.3M-1.3%	$242.4M+12.5%	$215.4M-7.2%
Accrued expenses	$175.3M-6.9%	$188.2M+21.3%	$155.2M-15.6%	$183.8M+12.5%
Deferred revenue	——	——	——	——
Current portion of long-term debt	$0—	$0-100%	$134M+5,991%	$2.2M-95.0%
Operating lease liabilities, current	$22.7M+26.8%	$17.9M+1.1%	$17.7M+10.6%	$16M+72.0%
Finance Lease Liability, Current	$1.5M+66.7%	$900K—	——	——
Contract liabilities	$53.7M+0.9%	$53.2M-1.3%	$53.9M-21.0%	$68.2M+11.3%
Income taxes payable	$28.1M-10.8%	$31.5M+89.8%	$16.6M-33.1%	$24.8M-5.7%
Total current liabilities	$654.9M+19.0%	$550.4M-18.1%	$671.8M+29.4%	$519M-12.6%
Long-term debt	$202.8M+0.1%	$202.6M+178%	$72.8M-64.8%	$206.7M-1.0%
Operating lease liabilities, non-current	$95.6M+16.9%	$81.8M-3.2%	$84.5M-9.1%	$93M+47.6%
Finance Lease Liabilities (Total)	$5.1M+70.0%	$3M—	——	$0—
Operating Lease Liabilities (Total)	$118.3M+18.7%	$99.7M-2.4%	$102.2M-6.2%	$109M+50.8%
Finance lease liabilities	$3.6M+71.4%	$2.1M—	——	$0—
Other non-current liabilities	$75.2M+20.9%	$62.2M+6.3%	$58.5M+13.4%	$51.6M+35.1%
Total liabilities	$19.9M-38.8%	$32.5M+101%	$16.2M-13.8%	$18.8M-19.0%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	200M+964%	18.8M0.0%	18.8M0.0%	18.8M0.0%
Additional paid-in capital	$0-100%	$22.1M-81.6%	$120.2M-48.2%	$232.2M-6.7%
Retained earnings	$4.37B+10.6%	$3.96B+12.3%	$3.52B+17.9%	$2.99B+21.6%
Accumulated other comprehensive income (loss)	-$105.5M+59.1%	-$258.1M-79.5%	-$143.8M+21.4%	-$183M-14.7%
Treasury stock	$1.11B+5.2%	$1.06B+65.8%	$637.6M+71.9%	$370.9M+61.6%
Total stockholders' equity	$3.18B+18.4%	$2.68B-6.9%	$2.88B+7.3%	$2.68B+15.0%
Total liabilities and stockholders' equity	$4.27B+17.2%	$3.64B-4.9%	$3.83B+5.9%	$3.62B+9.1%
Finished goods	$177.5M+22.5%	$144.9M-17.2%	$175.1M+6.1%	$165.1M+2.5%
Other current assets	$168.6M+36.0%	$124M-8.7%	$135.8M+31.8%	$103M-8.0%
Derivative Assets - Not Designated as Hedging Instruments	$7.6M-58.5%	$18.3M+732%	$2.2M-51.1%	$4.5M-69.6%
Deferred Tax Assets and Other Non-Current Assets	$80.1M+7.8%	$74.3M+249%	$21.3M-44.5%	$38.4M-2.0%
Net Investment in Lease	$117M+12.0%	$104.5M+5.3%	$99.2M-5.0%	$104.4M+50.6%
Deferred tax assets	$38.4M+47.7%	$26M+1.2%	$25.7M-60.8%	$65.6M+35.3%
Other intangible assets—net	$7.7M-28.7%	$10.8M-28.5%	$15.1M-17.9%	$18.4M-20.0%
Investments	$212.3M+5.0%	$202.1M-3.8%	$210M+2.5%	$204.9M-1.3%
Operating lease right-of-use assets	$117M+12.0%	$104.5M+5.3%	$99.2M-5.0%	$104.4M+50.6%
Other non-current assets	$80.1M+7.8%	$74.3M+249%	$21.3M-44.5%	$38.4M-2.0%
Property, plant and equipment at cost	$3.22B+8.0%	$2.99B+9.1%	$2.74B+14.7%	$2.39B+7.7%
Operating Lease Right-of-Use Assets in Other Assets	$117M+12.0%	$104.5M+5.3%	$99.2M-5.0%	$104.4M+50.6%
Software and Technology Licenses, Net	$80.1M+7.8%	$74.3M+249%	$21.3M-44.5%	$38.4M-2.0%
Other Commercial Liabilities	$39.2M—	——	——	——
Accrued Income Taxes, Current	$28.1M-10.8%	$31.5M+89.8%	$16.6M-33.1%	$24.8M-5.7%
Accrued Liabilities, Current	$39.2M—	——	——	——
Accrued salaries, wages and benefits	$135.9M+84.9%	$73.5M-30.6%	$105.9M+37.9%	$76.8M-34.0%
Other accrued liabilities	$175.3M-6.9%	$188.2M+21.3%	$155.2M-15.6%	$183.8M+12.5%
Finance Lease Liability Payment Due	——	——	——	——
Finance Lease Liability - Undiscounted Excess Amount	——	——	——	——
Lease Liability Payments - 2020 (Remaining Three Months)	——	——	$20.9M—	——
Lease Liability Payments - 2021	——	——	——	——
Operating Lease Liability Payments - 2024 (Lessee)	——	——	$15.7M-13.3%	$18.1M+69.2%
Operating Lease Liability Payments - 2025 (Lessee)	——	——	$9.5M-29.1%	$13.4M+63.4%
Lease Liability Payments - Due Year Two	——	——	$15.7M-13.3%	$18.1M+69.2%
Lease Liability Payments - Due Year Three	——	——	$11.2M-30.0%	$16M+60.0%
Lease Liability Payments - Due Year Four	——	——	$9.5M-29.1%	$13.4M+63.4%
Lease Liability Payments - Remainder of Fiscal Year	——	——	$18.7M-1.6%	$19M+65.2%
Operating Lease Liability Payments Due	——	——	$118.1M-6.8%	$126.7M+46.6%
Operating Lease Liability - Undiscounted Excess Amount	——	——	$15.9M-10.2%	$17.7M+25.5%
Contingent Consideration Liability (Non-Current)	$2.2M-26.7%	$3M-16.7%	$3.6M-23.4%	$4.7M+27.0%
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$200K-50.0%	$400K+100%	$200K-33.3%	$300K-40.0%
Deferred Compensation Liability (Non-Current)	$13.5M-12.3%	$15.4M-17.2%	$18.6M-2.6%	$19.1M-33.9%
Operating Lease Liability Payments - 2027 (Lessee)	——	——	$11.2M+19.1%	$9.4M+28.8%
Operating Lease Liability Payments - 2028 (Lessee)	——	——	$9.5M-29.1%	$13.4M+63.4%
Long-Term Debt - Fair Value	$202.4M+0.9%	$200.5M-1.9%	$204.4M—	——
Retirement and nonpension postretirement benefit obligations	$29M+2.8%	$28.2M-4.7%	$29.6M+5.0%	$28.2M-30.4%
Total Carrying Value of Debt	$203M0.0%	$203M-1.9%	$207M-1.1%	$209.2M-17.5%
Unrecognized Tax Benefits	$56.1M—	——	——	——
Common Stock Par Value Per Share	$0.250.0%	$0.250.0%	$0.250.0%	$0.250.0%
Common Stock Shares Issued	75.3M0.0%	75.3M0.0%	75.3M0.0%	75.3M0.0%
Convertible Preferred Stock Authorized Shares	3M0.0%	3M0.0%	3M0.0%	3M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively	$18.8M0.0%	$18.8M0.0%	$18.8M0.0%	$18.8M0.0%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Share Repurchase Authorization Limit	——	550K—	——	——
Shares Reserved for Future Issuance Under Stock Plans	——	——	——	——
Cumulative Cost Basis	$3.22B+8.0%	$2.99B+9.1%	$2.74B+14.7%	$2.39B+7.7%
Business Combination, Contingent Consideration, Liability	$2.2M-26.7%	$3M-16.7%	$3.6M-23.4%	$4.7M+27.0%
Common stock, par value (in dollars per share)	$0.250.0%	$0.250.0%	$0.250.0%	$0.250.0%
Common stock, shares authorized (in shares)	$200M0.0%	$200M0.0%	$200M0.0%	$200M0.0%
Common stock, shares issued (in shares)	$75.3M0.0%	$75.3M0.0%	$75.3M0.0%	$75.3M0.0%
Common Stock, Shares, Outstanding	$72M-0.4%	$72.3M-1.6%	$73.5M-0.8%	$74.1M-0.1%
Contract with Customer, Asset, after Allowance for Credit Loss	$11.9M-48.9%	$23.3M+8.4%	$21.5M+31.9%	$16.3M+11.6%
Contract with Customer, Liability	$53.7M+0.9%	$53.2M-1.3%	$53.9M-21.0%	$68.2M+11.3%
Long-term debt, gross	$203M0.0%	$203M-1.9%	$207M-1.1%	$209.2M-17.5%
Debt Instrument, Fair Value Disclosure	$202.4M+0.9%	$200.5M-1.9%	$204.4M—	——
Deferred Compensation Liability, Classified, Noncurrent	$13.5M-12.3%	$15.4M-17.2%	$18.6M-2.6%	$19.1M-33.9%
Deferred compensation plan assets	$10M-9.9%	$11.1M+8.8%	$10.2M-18.4%	$12.5M-19.4%
Deferred income taxes	$23M+12.2%	$20.5M+61.4%	$12.7M-11.2%	$14.3M+192%
Current maturities of long-term debt	$1.5M+66.7%	$900K—	——	——
Finance Lease Liability Payments Due	——	——	——	——
2027	——	——	——	——
Finance Lease Liability Payments Due Year Four	——	——	——	——
Finance Lease Liability Payments Due Year Three	——	——	——	——
Finance Lease Liability Payments Due Year Two	——	——	——	——
Thereafter	——	——	——	——
Finance Lease Liability Undiscounted Excess Amount	——	——	——	——
Finance Lease, Right-of-Use Asset, after Accumulated Amortization	$34.7M+16.8%	$29.7M—	——	——
Lessee Operating Lease Liability Payments Due	——	——	$118.1M-6.8%	$126.7M+46.6%
Thereafter	——	——	$42.1M—	——
Lessee Operating Lease Liability Undiscounted Excess Amount	——	——	$15.9M-10.2%	$17.7M+25.5%
Operating Lease Weighted Average Discount Rate Percent	$0.05+17.0%	$0.04+12.4%	$0.04+9.2%	$0.03-9.2%
Deferred compensation liabilities	$10.1M-9.8%	$11.2M+7.7%	$10.4M-18.1%	$12.7M-21.1%
Preferred Stock, Shares Authorized	$3M0.0%	$3M0.0%	$3M0.0%	$3M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	——	——	——
Incentive stock program, shares reserved for future grants (in shares)	——	——	——	——
Treasury stock, shares (in shares)	$3.3M+10.0%	$3M+66.7%	$1.8M+50.0%	$1.2M—
Unamortized Debt Issuance Expense	$200K-50.0%	$400K+100%	$200K-33.3%	$300K-40.0%
Unrecognized tax benefits	$56.1M—	——	——	——
Remainder of Fiscal Year 2024	——	——	$20.9M—	——
Weighted-Average Discount Rate	4.2%-0.6%	4.8%—	——	——
Weighted-Average Discount Rate - Finance Leases	$0.04-13.5%	$0.05—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about West Pharmaceutical Services.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are West Pharmaceutical Services's total assets?: West Pharmaceutical Services (WST) holds $4.1B in total assets, up 13.6% year over year.
How much debt does West Pharmaceutical Services have?: West Pharmaceutical Services carries $321.0M in total debt against $3.0B of shareholders' equity, a debt-to-equity ratio of 0.11.
How much cash does West Pharmaceutical Services have?: West Pharmaceutical Services holds $521.4M in cash and equivalents.
Can West Pharmaceutical Services cover its short-term obligations?: Its current ratio is 2.71 — current assets exceed current liabilities.
Where does West Pharmaceutical Services's balance sheet data come from?: Every line is extracted from West Pharmaceutical Services's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.